Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $191.9 million.

  • Lifecore Biomedical, Inc. \De\'s Total Liabilities fell 407.33% to $191.9 million in Q2 2025 from the same period last year, while for May 2025 it was $191.9 million, marking a year-over-year decrease of 407.33%. This contributed to the annual value of $191.9 million for FY2025, which is 407.33% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Total Liabilities stood at $191.9 million for Q2 2025, which was down 407.33% from $190.3 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Total Liabilities high stood at $304.7 million for Q1 2021, and its period low was $163.1 million during Q1 2023.
  • Moreover, its 5-year median value for Total Liabilities was $201.8 million (2023), whereas its average is $214.4 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Total Liabilities plummeted by 4036.48% in 2022 and then skyrocketed by 1689.69% in 2023.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Total Liabilities stood at $265.9 million in 2021, then decreased by 22.96% to $204.8 million in 2022, then fell by 0.66% to $203.5 million in 2023, then decreased by 3.86% to $195.6 million in 2024, then fell by 1.9% to $191.9 million in 2025.
  • Its Total Liabilities was $191.9 million in Q2 2025, compared to $190.3 million in Q1 2025 and $195.6 million in Q4 2024.